Anti-SARS-CoV-2 inactivated vaccine in patients with ANCA-associated vasculitis: Immunogenicity, safety, antibody decay and the booster dose (2023)
- Authors:
- USP affiliated authors: CAPARBO, VALÉRIA DE FALCO - FM ; SILVA, CLOVIS ARTUR ALMEIDA DA - FM ; SHINJO, SUELI MIEKO OBA - FM ; BONFA, ELOISA SILVA DUTRA DE OLIVEIRA - FM
- Unidade: FM
- DOI: 10.1016/j.clinsp.2022.100150
- Subjects: IMUNOGENÉTICA; COVID-19; VACINAS VIRAIS
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
PEREIRA, Rosa Maria Rodrigues et al. Anti-SARS-CoV-2 inactivated vaccine in patients with ANCA-associated vasculitis: Immunogenicity, safety, antibody decay and the booster dose. Clinics, v. 78, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/52881. Acesso em: 04 jun. 2024. -
APA
Pereira, R. M. R., Dagostin, M. A., Caparbo, V. F., Sales, L. P., Pasoto, S. G., Silva, C. A., et al. (2023). Anti-SARS-CoV-2 inactivated vaccine in patients with ANCA-associated vasculitis: Immunogenicity, safety, antibody decay and the booster dose. Clinics, 78. doi:10.1016/j.clinsp.2022.100150 -
NLM
Pereira RMR, Dagostin MA, Caparbo VF, Sales LP, Pasoto SG, Silva CA, Yuki EFN, Saad CGS, SHINJO SK, BONFA E. Anti-SARS-CoV-2 inactivated vaccine in patients with ANCA-associated vasculitis: Immunogenicity, safety, antibody decay and the booster dose [Internet]. Clinics. 2023 ; 78[citado 2024 jun. 04 ] Available from: https://observatorio.fm.usp.br/handle/OPI/52881 -
Vancouver
Pereira RMR, Dagostin MA, Caparbo VF, Sales LP, Pasoto SG, Silva CA, Yuki EFN, Saad CGS, SHINJO SK, BONFA E. Anti-SARS-CoV-2 inactivated vaccine in patients with ANCA-associated vasculitis: Immunogenicity, safety, antibody decay and the booster dose [Internet]. Clinics. 2023 ; 78[citado 2024 jun. 04 ] Available from: https://observatorio.fm.usp.br/handle/OPI/52881 - Polimorfismo do antagonista do receptor da interleucina 1 (IL1-RA) associado à cardite grave e susceptibilidade à febre reumática
- Pancreatitis Subtypes Survey in 852 Childhood-Onset Systemic Lupus Erythematosus Patients: A Multicenter Cohort
- Favorable rituximab response in patients with refractory idiopathic inflammatory myopathies
- Doença periodontal em doenças reumáticas pediátricas
- Abatacept Related Infections: No Association with Gammaglobulin Reduction
- Lupus nephritis-related issues during COVID-19 pandemic quarantine
- Initial Benchmarking of the Quality of Medical Care in Childhood-Onset Systemic Lupus Erythematosus
- Pandemic non-adjuvanted influenza A H1N1 vaccine in a cohort of patients with systemic sclerosis
- Pediatric rheumatic disease patients: time to extend the age limit of adolescence?
- Behçet's discase activity: an important factor for immunogenicity of unadjuvanted influenza A/H1N1 vaccine
Informações sobre o DOI: 10.1016/j.clinsp.2022.100150 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
